Predicting Esophageal Cancer Borders Using PET-Imaging

The study examines the diagnostic precision of endosonography, mpMRI and PET/CT in defining tumor boundaries and tumor spread before and after neoadjuvant therapy and definitive surgery.

Trial Details

NCT ID
NCT06408116
Phase
PHASE2
Sponsor
University Hospital Heidelberg
Status
RECRUITING
Cancer Type
Adenocarcinoma Esophageal Cancer
Interventions
  • photon
  • surgical therapy
  • Chemotherapy
Locations (sample)
  • Heidelberg, Germany|49.40768,8.69079

Key Eligibility Criteria

  • Histologically confirmed adenocarcinoma or squamous cell carcinoma of the esophagus, including AEG I and AEG II tumors in the primary situation
  • Planned surgical treatment of esophageal carcinoma
  • Possible staging advantage through FAPI PET/CT diagnostics
  • Patient information and written consent

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Adenocarcinoma Esophageal Cancer Trials on Trialify →